课题基金 / 基金详情

Development of polymer medicines production system ulilzing polarized epithelial culturing method.

Development of polymer medicines production system ulilzing polarized epithelial culturing method.
利用偏振上皮培养法开发高分子药物生产系统。
批准号:
04556009
负责人:
KITAGAWA Yasuo
金额:
$13.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993

项目摘要

项目成果

KITAGAWA Yasuo的其他基金

相似基金

相关文献

中文摘要
翻译
极化上皮细胞的特征在于具有两个质膜结构域,即顶侧结构域和基底侧结构域,具有不同的结构和功能。上皮细胞的极性不仅限于质膜成分,而且分泌蛋白也以极化方式释放。MDCK细胞是一种典型的犬肾上皮细胞系,已被广泛用于研究膜脂和蛋白质载体转运的分子机制。促红细胞生成素(Epo)是红细胞生成的主要生理调节因子,通过刺激红系前体细胞的增殖和分化而发挥作用。我们发现重组人Epo优先从MDCK细胞的顶端结构域分泌。利用这种极化分泌,我们已经开发了一个中试系统,在工业规模生产Epo。我们收集了设计中空纤维系统的基本信息,其中Epo将在纤维内部或外部释放。
英文摘要
Polarized epithelial cells are characterized by two plasma membrane domains, apical and basolateral domains, having different structure and functions. The polarity of epithelial cells is not only restricted to plasma membrane components but secretory proteins are also released in a polarized fashion. MDCK cells are a typical epithelial cell line derived from dog kidney and have been widely used to investigate molecular mechanism of vectorial transport of membrane lipids and proteins. Erythropoietin (Epo) is a major physiological regulator of erythropoiesis by stimulating proliferation and differentiation of erythroid precursor cells. We here found that recombinant human Epo is preferentially secreted from the apical domain of MDCK cells. Taking advantage of this polarized secretion, we have developed a pilot system of producing Epo in industrial scale. We have collected basic information of deigning hollow-fiber system in which Epo will be released either inside or outside of the fiber.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
Jeon,H.,Ono,M.,Kumagai,C.,and Kitagawa,Y.: "Subunit assembly of lominin subunits in cultured animal cells" Animal Cell Technology. (1993)
Jeon,H.、Ono,M.、Kumagai,C. 和 Kitakawa,Y.:“培养动物细胞中 lominin 亚基的亚基组装”动物细胞技术。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Taniguchi,Y.,and Kitagawa,Y.: "The differentiation-dependeut inhibition of SV40 promatky/enhancer activity in 3T3-L1 cells is wediated through promoter and not ouhaucer soquence" Cytotechnology. (1993)
Taniguchi, Y. 和 Kitakawa, Y.:“3T3-L1 细胞中 SV40 promatky/增强子活性的分化依赖性抑制是通过启动子而不是 ouhaucer 序列进行的”细胞技术。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Taniguchi.Y.and Kitagawa.Y.: "The differentiation-dependent inhibition of SV40 promoter/enhancer aofivity in 3T3-L1 cells is mediated through promoter and not enhancer sequence" Cytotechnology. 11. 175-182 (1993)
Taniguchi.Y. 和 Kitakawa.Y.:“3T3-L1 细胞中 SV40 启动子/增强子活性的分化依赖性抑制是通过启动子而不是增强子序列介导的”细胞技术。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Inagaki.T.,Matsushima M.,Ohshima.M.,and Kitagawa.Y.: "Regulation of mitochordrial gene oxpression by mterforouos" Animal Cell Technology;Basic & Applied Aspects. 5. 49-55 (1993)
Inagaki.T.、Matsushima M.、Ohshima.M. 和 Kitakawa.Y.:“mterforouos 调节线粒体基因氧化”动物细胞技术;基础
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 19 条
    Development of mesenchymal stem cell engineering for reconstructive therapy
    • 批准号:
      15208034
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $33.45万
    • 财政年份:
      2003
    • 负责人:
      KITAGAWA Yasuo
    • 依托单位:
    Super molecular association of laminin-8 creating contact structure between capillary endothelial cells and adipocytes.
    • 批准号:
      13460039
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.62万
    • 财政年份:
      2001
    • 负责人:
      KITAGAWA Yasuo
    • 依托单位:
    SEARCH FOR THE DOMAIN IN LAMININ α4 CHAIN RESPONSIBLE TO ANGIOGENESIS
    • 批准号:
      11460154
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $9.66万
    • 财政年份:
      1999
    • 负责人:
      KITAGAWA Yasuo
    • 依托单位:
    Study on the function of laminin by producing transgenic mice and fruit flies
    • 批准号:
      09460048
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $2.24万
    • 财政年份:
      1997
    • 负责人:
      KITAGAWA Yasuo
    • 依托单位:
    海外基金